Latest Biotech News

The biotech sector navigates complex regulatory and financial dynamics. The Supreme Court upheld cuts to $783 million in NIH research funds linked to diversity, equity, and inclusion efforts, a...

Recent studies have propelled neuro-oncology forward with new molecular insights and therapeutic avenues for central nervous system (CNS) tumors. A comprehensive molecular atlas of rare CNS...

Progress in neurodegenerative disease research includes targeted therapies and biomarker advancements. A brain-delivered antibody designed to clear alpha-synuclein aggregates offers potential...

Groundbreaking research has identified novel molecular drivers and therapeutic targets across multiple cancer types. Studies reveal tumor suppressive roles for collagen VI alpha 6 in breast cancer...

Recent financial and corporate developments shape the biotech industry’s trajectory. Kriya Therapeutics secured $313 million to advance gene therapies targeting chronic diseases despite emerging...

Artificial intelligence integration is pushing the boundaries of biotechnology and diagnostics. Natera launched an AI foundational model platform blending genomic, clinical, and imaging data to...

The biopharmaceutical regulatory environment is undergoing significant change. The FDA announced daily publication of adverse event reports to enhance post-market surveillance, marking a shift...

Cutting-edge research is reshaping energy storage paradigms. AI-powered models from Uppsala University promise improvements in lithium-ion battery lifespan and safety, addressing critical hurdles...

Recent molecular biology breakthroughs expand disease understanding and therapeutic avenues. Novel insights demonstrate potassium- and calcium-modified ilmenite oxygen carriers effecting greener...

The immuno-oncology field reveals promising advancements in tumor microenvironment modulation and therapy. Studies identify boosting cytotoxic T cell activity by reprogramming regulatory T cells...

Emerging technologies in AI, quantum computing, and photonics forge new paths for scientific innovation. Novel quantum network nodes developed at the University of Innsbruck enhance quantum...

Ionis Pharmaceuticals received FDA approval for Dawnzera (donidalorsen), an antisense therapy preventing attacks in hereditary angioedema (HAE), a rare genetic condition characterized by painful...

Gilead Sciences expanded its cell therapy portfolio by acquiring Interius BioTherapeutics for $350 million, gaining in vivo CAR-T technology that enables direct genetic modification of immune...

Recent studies demonstrate the growing role of artificial intelligence in biotech innovation. AI identified Bufalin as a novel estrogen receptor degrader, presenting potential new hormone...

Cutting-edge biomarker studies offer new diagnostic and therapeutic avenues. CHI3L1 emerges as a promising biomarker to improve liver disease management, while WTAP’s role in m6A-mediated DNA...

New research advances Parkinson’s disease (PD) diagnosis and management. Synthetic MRI techniques differentiate motor subtypes by analyzing brain volume and myelin alterations. Wearable...

Innovative immunotherapy developments promise improved cancer outcomes. CRISPR screening platforms for human NK cells identify new therapeutic targets, potentially enhancing CAR NK cell efficacy....

Significant capital flows continue shaping biotech innovation landscape. Kriya Therapeutics raises $313 million to advance gene therapies in ophthalmic, metabolic, and neurologic diseases. Calidi...

Researchers have unveiled novel electrochemical detection techniques using phosphorus-doped graphitic carbon nitride electrodes for sustainable antibiotic detection. Advances in lithium-ion...

Groundbreaking research reveals the brain retains stable cortical body maps even after limb amputation, challenging previous assumptions about neural plasticity. Studies elucidate the role of...